Hong Kong | Jotup

American Airlines Announces Pricing of Senior Secured Notes

Retrieved on:

星期五, 十一月 17, 2023

Sale, Term loan, Senior, AAL, Security (finance), American Airlines Group, Risk, Parent, Airport, Analysis, Person, American Airlines, SEC Rule 144A, Regulation, Financial condition report, Result, Note, Hong Kong

FORT WORTH, Texas, Nov. 17, 2023 (GLOBE NEWSWIRE) -- American Airlines, Inc. (the “Company”), a subsidiary of American Airlines Group Inc. (the “Parent”)(NASDAQ: AAL), today announced that it priced $1.0 billion aggregate principal amount of its 8.50% senior secured notes due 2029 (the “Notes”), representing an upsize of $250.0 million from the previously announced offering amount.

Key Points:

FORT WORTH, Texas, Nov. 17, 2023 (GLOBE NEWSWIRE) -- American Airlines, Inc. (the “Company”), a subsidiary of American Airlines Group Inc. (the “Parent”)(NASDAQ: AAL), today announced that it priced $1.0 billion aggregate principal amount of its 8.50% senior secured notes due 2029 (the “Notes”), representing an upsize of $250.0 million from the previously announced offering amount.
The Company expects to use the net proceeds from the offering of the Notes, together with the net proceeds from the Term Loan and cash on hand, to redeem all of its outstanding 11.75% Senior Secured Notes due 2025 (the “11.75% Senior Secured Notes”).
The Notes and the Term Loan will be guaranteed on a senior unsecured basis by the Parent.
Neither this press release nor anything contained herein shall constitute a notice of redemption with respect to the 11.75% Senior Secured Notes.

Shineco Announces the Appointment of Two New Executive Officers

Retrieved on:

星期五, 十一月 17, 2023

Effective November 13, 2023, Shineco’s Board of Directors appointed Ms. Xiaohui Wang as Executive President of the Company.

Key Points:

Effective November 13, 2023, Shineco’s Board of Directors appointed Ms. Xiaohui Wang as Executive President of the Company.
From February 1991 to March 2000, Ms. Wang worked as Manager at Chongqing Silk Import and Export Company where she was responsible for the company's import and export management.
Effective November 13, 2023, Shineco’s Board of Directors appointed Mr. Chi Keung Yan as the Chief Strategy Officer of the Company.
Ms. Jennifer, CEO of Shineco, said, "We are pleased to welcome Ms. Wang and Mr. Yan to our leadership team.

American Airlines Announces Proposed Offering of Senior Secured Notes and New Term Loan

Retrieved on:

星期四, 十一月 16, 2023

Sale, Term loan, Senior, AAL, Security (finance), American Airlines Group, Risk, European, Parent, Airport, Analysis, Person, American Airlines, SEC Rule 144A, Regulation, Financial condition report, Result, Note, Hong Kong

FORT WORTH, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- American Airlines, Inc. (the “Company”), a subsidiary of American Airlines Group Inc. (the “Parent”)(NASDAQ: AAL), today announced a proposed private offering of $750 million aggregate principal amount of senior secured notes due 2029 (the “Notes”).

Key Points:

FORT WORTH, Texas, Nov. 16, 2023 (GLOBE NEWSWIRE) -- American Airlines, Inc. (the “Company”), a subsidiary of American Airlines Group Inc. (the “Parent”)(NASDAQ: AAL), today announced a proposed private offering of $750 million aggregate principal amount of senior secured notes due 2029 (the “Notes”).
The Company also announced it intends to borrow up to $750 million in aggregate principal amount of term loans (the “Term Loan”) under a new senior secured credit facility.
The Company expects to use the net proceeds from the offering of the Notes, together with the net proceeds from the Term Loan and cash on hand, to redeem $1.5 billion of its existing 11.75% Senior Secured Notes due 2025 (the “11.75% Senior Secured Notes”).
Neither the consummation of the Notes offering, nor the consummation of the Term Loan, is conditioned upon the consummation of the other financing.

Moxian Announces Name Change to Abits Group Inc

Retrieved on:

星期四, 十一月 16, 2023

BVI, Hong Kong

Hong Kong, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Moxian (BVI) Inc (the “Company”) (NASDAQ: MOXC), a company engaged in bitcoin mining and related services in the United States, today announced that it has changed its corporate name from Moxian (BVI) Inc to Abits Group Inc.

Key Points:

Hong Kong, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Moxian (BVI) Inc (the “Company”) (NASDAQ: MOXC), a company engaged in bitcoin mining and related services in the United States, today announced that it has changed its corporate name from Moxian (BVI) Inc to Abits Group Inc.
In addition, the Company’s ticker symbol on the Nasdaq Capital Market will be changed to “ABTS” from “MOXC” effective before the opening of trading on November 17, 2023.
It also coincides with the launch of a mining center in Tennessee, which is driven by a new generation of innovative and sustainable hydro-power.”
The corporate name change to Abits Group Inc does not affect the rights of the Company’s shareholders and no action is required by shareholders with respect to the name change.
The number of outstanding ordinary shares of the Company is also not affected by the name and ticker symbol changes.

Aurora Mobile Limited Announces Third Quarter 2023 Unaudited Financial Results

Retrieved on:

星期四, 十一月 16, 2023

SHENZHEN, China, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial results for the third quarter ended September 30, 2023.

Key Points:

SHENZHEN, China, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (“Aurora Mobile” or the “Company”) (NASDAQ: JG), a leading provider of customer engagement and marketing technology services in China, today announced its unaudited financial results for the third quarter ended September 30, 2023.
Net loss attributable to Aurora Mobile Limited’s shareholders was RMB6.8 million (US$0.9 million), compared with a net loss attributable to Aurora Mobile Limited’s shareholders of RMB20.4 million for the same quarter last year.
Mr. Weidong Luo, Chairman and Chief Executive Officer of Aurora Mobile, commented, “This 3rd quarter of 2023 has been a great quarter for us operationally and financially.
Statements that are not historical facts, including but not limited to statements about Aurora Mobile’s beliefs and expectations, are forward-looking statements.

Apollomics Announces the First Approval of Vebreltinib for MET Exon 14 Skip Non-Small Cell Lung Cancer

Retrieved on:

星期四, 十一月 16, 2023

NDA, National Medical Products Administration, Food, Aviston, Illinois, NMPA, APLM, Patient, FDA, Lung cancer, MET, NSCLC, Partnership, Cancer, Pharmaceutical industry, Hong Kong

FOSTER CITY, Calif., Nov. 16, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, today announced that its partner in China, Avistone Biotechnology Co. Ltd., received conditional approval from the National Medical Products Administration (NMPA) of China for the commercialization of vebreltinib to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC).

Key Points:

"The NMPA approval of vebreltinib is an important milestone toward providing a new treatment option for patients with MET exon 14 skipping NSCLC in China.
Apollomics extends its full support and congratulations to Avistone on this significant achievement," said Guo-Liang Yu, Ph.D., Chairman and Chief Executive Officer of Apollomics.
By targeting c-Met dysregulation, vebreltinib offers a potential breakthrough for patients with MET exon 14 skipping NSCLC and other cancers driven by c-Met alterations, i.e.
Patients with MET exon 14 skipping mutations, comprise approximately 3% to 4% of all NSCLC cases, face significant challenges due to limited treatment options.

Floship Selected to Join HKSTP Elite Programme, Affirming Innovativeness & Growth Potential

Retrieved on:

星期四, 十一月 16, 2023

Mobility, FedEx, HKSTP, Software, Partnership, Growth, Hong Kong

Being named to the Elite Programme is a significant milestone for Floship, as it joins an exclusive portfolio of the most innovative companies in Hong Kong.

Key Points:

Being named to the Elite Programme is a significant milestone for Floship, as it joins an exclusive portfolio of the most innovative companies in Hong Kong.
Expressing his excitement, Joshua Tsui, CEO of Floship, stated, “Being selected to join the HKSTP Elite Programme is a tremendous privilege and adds to what has already been a momentous year in our growth.
To showcase its innovative technology, Floship participated in the HKSTP Openhouse event, Hong Kong’s largest platform for technology and innovation, on 7 November.
In addition, Floship will present its circular logistics solutions as part of HKSTP’s connective Digital Membership Program under the Mobility & Logistics Solutions Catalogue.

Treasure Global Reports First Quarter Fiscal Year 2024 Results

Retrieved on:

星期三, 十一月 15, 2023

NEW YORK and KUALA LUMPUR, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Treasure Global Inc (NASDAQ: TGL) (“TGL,” or the “Company”), an innovative technology solutions provider, today reported its financial results for the first quarter of fiscal 2024 ended September 30, 2023, and provided a business update.

Key Points:

A total of 1.33 million transactions were transacted by our registered users over the first quarter and quarter to date for fiscal year 2024.
Total revenues for the first quarter ended September 30, 2023, were $13.5 million, compared with $15.6 million for the first quarter in 2023.
Gross profit for the first quarter 2024 was approximately $0.16 million, a 338% improvement year-on-year, from approximately $0.04 million for the first quarter 2023.
Net loss of approximately $2.1 million for the first quarter of 2024, compared to $3.7 million for the first quarter of 2023.

Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results

Retrieved on:

星期三, 十一月 15, 2023

AGOURA HILLS, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, PDAC, DIPG, and COVID-19, today announced financial results for the three months ended September 30, 2023 (“Q3 2023”) as compared to the three months ended September 30, 2022 (“Q3 2022”).

Key Points:

AGOURA HILLS, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a developer of treatments for rare and orphan indications, including Parkinson's Disease, PDAC, DIPG, and COVID-19, today announced financial results for the three months ended September 30, 2023 (“Q3 2023”) as compared to the three months ended September 30, 2022 (“Q3 2022”).
The financial results are based on the Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 14, 2023.
Highlights for Q3 2023 and thereafter:
We have been enjoying the effects of the benefits of the JV transaction, between Dragon Overseas Limited (“Dragon”) and us, through the formation of GMP Biotechnology Limited (“GMP Bio” or “JV”) being reflected in our financial results.
“Commencing April 2022, with the culmination of the JV with Dragon, and continuing into 2023 till date, have been a good eighteen months for us.

Fortress Biotech Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Retrieved on:

星期二, 十一月 14, 2023

MIAMI, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on efficiently acquiring, developing and commercializing or monetizing promising therapeutic products and product candidates, today announced financial results and recent corporate highlights for the third quarter ended September 30, 2023.

Key Points:

Lindsay A. Rosenwald, M.D., Fortress’ Chairman, President and Chief Executive Officer, said, “In the third quarter of 2023, Fortress and our partner companies and subsidiaries continued to advance our diverse portfolio of drug candidates.
Journey Medical’s total product net revenues were $15.3 million for the third quarter of 2023, compared to third quarter 2022 total product net revenues of $16.0 million.
Fortress’ consolidated net revenue totaled $34.8 million for the third quarter of 2023, which included $15.3 million in net product revenue generated from our marketed dermatology products.
Consolidated selling, general and administrative expenses were $21.7 million for the third quarter of 2023, compared to $30.1 million for the third quarter of 2022.